Report post

What is the consensus rating for AbbVie stock?

AbbVie has received a consensus rating of Hold. The company's average rating score is 2.36, and is based on 6 buy ratings, 7 hold ratings, and 1 sell rating. According to analysts' consensus price target of $158.78, AbbVie has a forecasted downside of 1.8% from its current price of $161.61.

What is the history of AbbVie Inc. (ABBV) stock?

AbbVie has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. AbbVie Inc. is a US-based biopharma company with global operations. The company originated as the bio-pharma segment of Abbott Laboratories and was spun off in late 2012.

What is Abbvie Inc.'s stock symbol?

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

The World's Leading Crypto Trading Platform

Get my welcome gifts